Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)

Description

A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).

Conditions

Vertebral Artery Stenosis

Talk to us

Study Overview

On this page

Study Details

Study overview

A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).

Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)

Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)

Condition
Vertebral Artery Stenosis
Intervention / Treatment

-

Contacts and Locations

Jacksonville

Baptist Medical Center Jacksonville, Jacksonville, Florida, United States, 32207

Tampa

University of Southern Florida, Tampa, Florida, United States, 33606

Winfield

Northwestern Medicine Regional Medical Group, Winfield, Illinois, United States, 60190

Iowa City

University of Iowa, Iowa City, Iowa, United States, 52242

Bridgeton

SSM DePaul Hospital, Bridgeton, Missouri, United States, 63044

Saint Louis

Saint Louis University, Saint Louis, Missouri, United States, 63110

Cleveland

Cleveland Clinic, Cleveland, Ohio, United States, 44195

Toledo

Mercy Health Neuroscience Institute, Toledo, Ohio, United States, 43608

Memphis

Semmes Murphey Clinic, Memphis, Tennessee, United States, 38120

El Paso

Texas Tech University Health Science Center of El Paso, El Paso, Texas, United States, 79905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patients between 18 and 90 years of age
  • 2. Patient has experienced a posterior circulation ischemic event
  • 3. Patient has angiographically confirmed bilateral vertebral artery origin disease (Hypoplasia, occlusion, or stenosis).
  • 4. Patient has \>50% stenosis on the side being targeted for therapy
  • 1. Pregnant women
  • 2. Contrast Indication to the use of anti-platelet drugs
  • 3. There is tandem vertebral or basilar artery stenosis
  • 4. The serum creatinin is \>2.5
  • 5. Baseline modified Rankin score is \>3
  • 6. \< 5 years life expectancy

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

St. Louis University,

Randall Edgell, MD, PRINCIPAL_INVESTIGATOR, St. Louis University

Study Record Dates

2026-12